EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

Roshan Vaid iD, Ketan Thombare iD, Akram Mendez iD, Rebeca Burgos-Panadero iD, Anna Djos, Daniel Jachimowicz, Kristina Ihrmark Lundberg, Christoph Bartenhagen, Navinder Kumar, Conny Tümmler, Carina Sihlbom, Susanne Fransson iD und 5 weitere

Nucleic Acids Research · 21.03.2024 · 52 (5) · 2648-2671

DOI: 10.1093/nar/gkad1242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 05.01.2024. Verfasst von Roshan Vaid und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Methyltransferases, Neuroblastoma, RNA, Long Noncoding. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Cancerfonden, Barncancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telomerase-negative tumors maintain telomere length by alternative lengthening of telomeres (ALT), but the underlying mechanism behind ALT remains poorly understood. A proportion of aggressive neuroblastoma (NB), particularly relapsed tumors, are positive for ALT (ALT+), suggesting that a better dissection of the ALT mechanism could lead to novel therapeutic opportunities. TERRA, a long non-coding RNA (lncRNA) derived from telomere ends, localizes to telomeres in a R-loop-dependent manner and plays a crucial role in telomere maintenance. Here we present evidence that RNA modification at the N6 position of internal adenosine (m6A) in TERRA by the methyltransferase METTL3 is essential for telomere maintenance in ALT+ cells, and the loss of TERRA m6A/METTL3 results in telomere damage. We observed that m6A modification is abundant in R-loop enriched TERRA, and the m6A-mediated recruitment of hnRNPA2B1 to TERRA is critical for R-loop formation. Our findings suggest that m6A drives telomere targeting of TERRA via R-loops, and this m6A-mediated R-loop formation could be a widespread mechanism employed by other chromatin-interacting lncRNAs. Furthermore, treatment of ALT+ NB cells with a METTL3 inhibitor resulted in compromised telomere targeting of TERRA and accumulation of DNA damage at telomeres, indicating that METTL3 inhibition may represent a therapeutic approach for ALT+ NB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesNeuroblastomaRNA, Long NoncodingHumansAdenineR-Loop StructuresTelomereTelomere Homeostasis

Substanzen

AdenineMethyltransferasesRNA, Long NoncodingMETTL3 protein, human6-methyladenine

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
  • Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institute, and Pediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Medical Faculty, Cologne, Germany, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; Departm…
  • Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
  • Proteomics Core Facility, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Roshan Vaid, Ketan Thombare, Akram Mendez, Rebeca Burgos-Panadero, Susanne Fransson, Tanmoy Mondal

Förderung

  • Swedish Research Council
  • Cancerfonden
  • Barncancerfonden
  • Svenska Läkaresällskapet
  • Åke Wibergs Stiftelse
  • Kungl Vetenskaps- och Vitterhets-Samhället
  • Tore Nilsons Stiftelse and Bollan scholarship
  • Assar Gabrielsson Fond

Zitieren

APA

Vaid, R., Thombare, K., Mendez, A., Burgos-Panadero, R., Djos, A., Jachimowicz, D., Lundberg, K. I., Bartenhagen, C., Kumar, N., Tümmler, C., Sihlbom, C., Fransson, S., Johnsen, J. I., Kogner, P., Martinsson, T., Fischer, M., & Mondal, T. (2024). METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Research, 52(5), 2648-2671. https://doi.org/10.1093/nar/gkad1242

Vancouver

Vaid R, Thombare K, Mendez A, Burgos-Panadero R, Djos A, Jachimowicz D, et al. METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Research. 2024;52(5):2648-2671. doi:10.1093/nar/gkad1242

BibTeX
@article{Vaid2024,
  author = {Vaid, Roshan and Thombare, Ketan and Mendez, Akram and Burgos-Panadero, Rebeca and Djos, Anna and Jachimowicz, Daniel and Lundberg, Kristina Ihrmark and Bartenhagen, Christoph and Kumar, Navinder and Tümmler, Conny and Sihlbom, Carina and Fransson, Susanne and Johnsen, John Inge and Kogner, Per and Martinsson, Tommy and Fischer, Matthias and Mondal, Tanmoy},
  title = {METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma},
  journal = {Nucleic Acids Research},
  year = {2024},
  volume = {52},
  number = {5},
  pages = {2648--2671},
  doi = {10.1093/nar/gkad1242}
}
Kostenlos starten →